Skip to Content

Wart Remover

Medically reviewed by Drugs.com. Last updated on Aug 16, 2019.

Dosage form: plaster
Ingredients: SALICYLIC ACID 0.4g
Labeler: Pharmaplast SAE
NDC Code: 28691-0400

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Wart remover plaster

Drug Facts

Active ingredient

Salicylic acid 40% in a plaster vehicle

Purpose

Wart remover adhesive pads

Indications:
  • For the removal of common warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface.
  • For the removal of plantar warts on the bottom of the foot.
    The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

Warnings
  • For external use only
  • Do not use this product on irritated skin, on any area that is infected or reddened, if you are a diabetic, or if you have poor blood circulation.
  • If discomfort persists, see your doctor.
  • Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.

  • Keep out of reach of children.

Directions

For removal of Common and Plantar warts:

  • Wash affected area.
  • May soak wart in warm water for 5 minutes.
  • Dry area thoroughly.
  • Cut plaster to fit wart.
  • Apply medicated plaster.
  • Repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks.

Inactive ingredient

Pressure sensitive adhesive fabric

CURE-AID®

Pharmaplast

Amria – Alexandria
Egypt
www.Pharmaplast-online.com

Packaging

WART REMOVER 
salicylic acid plaster
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:28691-0400
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID0.4 g
Inactive Ingredients
Ingredient NameStrength
NATURAL LATEX RUBBER 
SILICON DIOXIDE 
POLYISOBUTYLENE (75000 MW) 
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) 
Packaging
#Item CodePackage Description
1NDC:28691-0400-120 PLASTER in 1 BOX
2NDC:28691-0400-210 PLASTER in 1 BOX
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358B10/07/2016
Labeler - Pharmaplast SAE (557735337)
Establishment
NameAddressID/FEIOperations
Pharmaplast SAE557735337manufacture(28691-0400)

 
Pharmaplast SAE